Unity Biotechnology, Inc. Annual Operating Income (Loss) in USD from 2016 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Unity Biotechnology, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2016 to 2024.
  • Unity Biotechnology, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$9.99M, a 30.1% decline year-over-year.
  • Unity Biotechnology, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$31.2M, a 30.2% increase year-over-year.
  • Unity Biotechnology, Inc. annual Operating Income (Loss) for 2024 was -$31.2M, a 30.2% increase from 2023.
  • Unity Biotechnology, Inc. annual Operating Income (Loss) for 2023 was -$44.7M, a 22.4% increase from 2022.
  • Unity Biotechnology, Inc. annual Operating Income (Loss) for 2022 was -$57.6M, a 1.6% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$31.2M +$13.5M +30.2% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-07
2023 -$44.7M +$12.9M +22.4% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-07
2022 -$57.6M -$907K -1.6% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-07
2021 -$56.7M +$37.3M +39.7% Jan 1, 2021 Dec 31, 2021 10-K 2024-04-15
2020 -$93.9M -$4.28M -4.77% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-15
2019 -$89.7M -$10.2M -12.8% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-15
2018 -$79.5M -$33.9M -74.2% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-23
2017 -$45.6M -$26.8M -142% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-11
2016 -$18.8M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.